fbpx
Medical Innovation Exchange

Provention snags $60M in private placement as future of diabetes therapy hangs in the balance

https://www.fiercebiotech.com/biotech/provention-sells-60m-stock-private-investors-teplizumabs-future-hangs-balance

Leave a Comment

Your email address will not be published.

Leave the field below empty!

This site uses Akismet to reduce spam. Learn how your comment data is processed.